Advertisement

Cancer Causes & Control

, Volume 22, Issue 5, pp 775–783 | Cite as

Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women

  • Geoffrey C. KabatEmail author
  • Mimi Kim
  • Amanda I. Phipps
  • Christopher I. Li
  • Catherine R. Messina
  • Jean Wactawski-Wende
  • Lewis Kuller
  • Michael S. Simon
  • Shagufta Yasmeen
  • Sylvia Wassertheil-Smoller
  • Thomas E. Rohan
Original paper

Abstract

Purpose

Little is known about the risk factors for triple-negative breast cancer (TNBC), which has a worse prognosis compared to hormone receptor-positive breast cancer. We examined the association of smoking and alcohol intake with TNBC and estrogen receptor-positive (ER+) breast cancer.

Methods

Among 148,030 women enrolled in the Women’s Health Initiative, 300 TNBC cases and 2,479 ER+ cases were identified over a median of 8.0 years of follow-up. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (95% CI).

Results

Cigarette smoking was not associated with TNBC, whereas drinkers had reduced risk compared to never drinkers. In contrast, both exposures showed slight positive associations with ER+ breast cancer: for women with ≥40 pack-years of smoking, the HR was 1.24, 95% CI 1.06–1.44; for women consuming ≥7 servings of alcohol per week, the HR was 1.26, 95% CI 1.06–1.50. Intakes of wine and hard liquor were also significantly positively associated with ER+ breast cancer.

Conclusions

These findings from a large cohort of postmenopausal women suggest that smoking and alcohol consumption are not associated with increased risk of TNBC, but may be modestly associated with increased risk of ER+ breast cancer.

Keywords

Breast neoplasms Triple-negative Estrogen receptor-positive Cigarette smoking Alcohol consumption Postmenopausal women 

Notes

Conflicts of interest

None.

References

  1. 1.
    Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137–2150PubMedCrossRefGoogle Scholar
  2. 2.
    Perou CM, Sørlie T, Eisen MB et al (2000) Molecular portraits of human breast tumors. Nature 406:747–752PubMedCrossRefGoogle Scholar
  3. 3.
    Sørlie T, Perou CM, Tibsirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874PubMedCrossRefGoogle Scholar
  4. 4.
    Carey LA, Winer E, Viale G, Cameron D, Gianni L (2010) Triple-negative breast cancer: disease entity or title of convenience. Nat Rev Clin Oncol. doi: 10.1038/nrclinonc.2010.154
  5. 5.
    Parise CA, Bauer KR, Brown MM, Caggiano V (2009) Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999–2004. Breast J 15:593–602PubMedCrossRefGoogle Scholar
  6. 6.
    Livasy CA, Karaca G, Nanda R et al (2006) Phenotypic evaluation of the basal-like subtype of invasive breast cancer. Mod Pathol 19:264–271PubMedCrossRefGoogle Scholar
  7. 7.
    Kreike B, van Kouwenhove M, Horlings H, et al. (2007) Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas. Breast Cancer Res 9:R65 doi: 10.1186/bcr1771
  8. 8.
    Dent R, Trudeau M, Pritchard KI et al (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13:4429–4434PubMedCrossRefGoogle Scholar
  9. 9.
    Haffty BG, Yang Q, Reiss M et al (2006) Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol 24:5652–5657PubMedCrossRefGoogle Scholar
  10. 10.
    Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor(PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer registry. Cancer 109:1721–1728PubMedCrossRefGoogle Scholar
  11. 11.
    Morris GJ, Naidu S, Topham AK et al (2007) Differences in breast carcinoma characteristics in newly diagnosed African-American and caucasian patients. Cancer 110:876–884PubMedCrossRefGoogle Scholar
  12. 12.
    Lund MJ, Trivers KF, Porter PL et al (2009) Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat 113:357–370PubMedCrossRefGoogle Scholar
  13. 13.
    Yang XR, Sherman ME, Rimm DL et al (2007) Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev 16:439–443PubMedCrossRefGoogle Scholar
  14. 14.
    Phipps AI, Malone KE, Porter PL, Daling JR, Li CI (2008) Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer 113:1521–1526PubMedCrossRefGoogle Scholar
  15. 15.
    Phipps AI, Malone KE, Porter PL, Daling JR, Li CI (2008) Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 17:2078–2086PubMedCrossRefGoogle Scholar
  16. 16.
    Millikan RC, Newman B, Tse C-K (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109:123–139PubMedCrossRefGoogle Scholar
  17. 17.
    Dolle JM, Daling JR, White E et al (2009) Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev 18:1157–1166PubMedCrossRefGoogle Scholar
  18. 18.
    Kwan ML, Kushi LH, Weltzien E et al (2009) Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res 11:R31. doi: 101186/bcr2261 PubMedCrossRefGoogle Scholar
  19. 19.
    Trivers KF, Lund MJ, Porter PL et al (2009) The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control 20:1071–1082PubMedCrossRefGoogle Scholar
  20. 20.
    Longnecker MP (1994) Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control 5:73–82PubMedCrossRefGoogle Scholar
  21. 21.
    Collaborative Group on Hormonal Factors in Breast Cancer (2002) Alcohol, tobacco and breast cancer–collaborative reanalysis of individual data from 53 epidemiological studies, including 58, 515 women with breast cancer and 95, 067 women with the disease. Br J Cancer 87:1234–1245CrossRefGoogle Scholar
  22. 22.
    Key J, Hodgson S, Omar RZ et al (2006) Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control 17:759–770PubMedCrossRefGoogle Scholar
  23. 23.
    Terry PD, Rohan TE (2002) Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol Biomarkers Prev 11:953–971PubMedGoogle Scholar
  24. 24.
    Ahern TP, Lash TL, Egan KM, Baron JA (2009) Lifetime tobacco smoke exposure and breast cancer incidence. Cancer Causes Control 20:1837–1844PubMedCrossRefGoogle Scholar
  25. 25.
    TheWomen’s Health Initiative Study Group (1998) Design of the Women’s Health Initiative clinical trial and observational study. Control Clin Trials 19:61–109CrossRefGoogle Scholar
  26. 26.
    Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M (2003) The Women’s Health Initiative observational study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 13:S107–S121PubMedCrossRefGoogle Scholar
  27. 27.
    Anderson GL, Manson J, Wallace R et al (2003) Implementation of the Women’s Health Initiative study design. Ann Epidemiol 13:S5–S17PubMedCrossRefGoogle Scholar
  28. 28.
    Curb JD, McTiernan A, Heckbert SR, et al. (2003) Outcomes ascertainment and adjudication methods in the women’s health initiative. Ann Epidemiol (9 Suppl): S122–S128Google Scholar
  29. 29.
    Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T (1999) Measurement characteristics of the Women’s Health Initiative food frequency questionnaire. Ann Epidemiol 9:178–187PubMedCrossRefGoogle Scholar
  30. 30.
    Kabat GC, Kim M, Kakani C, et al. (2010) Cigarette smoking in relation to risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women. Am J Epidemiol doi: 10.1093/aje/kwq159
  31. 31.
    O’Connell DL, Hulka BS, Chambless LE, Wilkinson WE, Deubner DC (1987) Cigarette smoking, alcohol consumption, and breast cancer risk. J Natl Cancer Inst 78:229–234PubMedGoogle Scholar
  32. 32.
    Rohan TE, Baron JA (1989) Cigarette smoking and breast cancer. Am J Epidemiol 129:36–42PubMedGoogle Scholar
  33. 33.
    Ewertz M (1990) Smoking and breast cancer risk in Denmark. Cancer Causes Control 1:31–37PubMedCrossRefGoogle Scholar
  34. 34.
    Chu SY, Stroup NE, Wingo PA, Lee NC, Peterson HB, Gwinn ML (1990) Cigarette smoking and the risk of breast cancer. Am J Epidemiol 131:244–253PubMedGoogle Scholar
  35. 35.
    Field NA, Baptiste MS, Nasca PC, Metzger BB (1992) Cigarette smoking and breast cancer. Int J Epidemiol 21:842–848PubMedCrossRefGoogle Scholar
  36. 36.
    Smith SJ, Deacon JM, Chilvers CE (1994) Alcohol, smoking, passive smoking and caffeine in relation to breast cancer risk in young women. UK National Case–control study group. Br J Cancer 70:112–119PubMedCrossRefGoogle Scholar
  37. 37.
    Baron JA, Newcomb PA, Longnecker MP et al (1996) Cigarette smoking and breast cancer. Cancer Epidemiol Biomarkers Prev 5:399–403PubMedGoogle Scholar
  38. 38.
    Egan KM, Stampfer MJ, Hunter D et al (2002) Active and passive smoking and breast cancer: prospective results from the nurses’ health study. Epidemiology 13:138–145PubMedCrossRefGoogle Scholar
  39. 39.
    Reynolds P, Hurley S, Goldberg DE et al (2004) Active smoking, household passive smoking, and breast cancer: evidence from the California teachers study. J Natl Cancer Inst 96:29–37PubMedCrossRefGoogle Scholar
  40. 40.
    Gram IT, Braaten T, Terry PD et al (2005) Breast cancer risk among women who started smoking as teenagers. Cancer Epidemiol Biomarkers Prev 14:61–66PubMedGoogle Scholar
  41. 41.
    Olson JE, Vachon CM, Vierkant RA et al (2005) Prepregnancy exposure to cigarette smoking and subsequent risk of postmenopausal breast cancer. Mayo Clin Proc 80:1423–1428PubMedCrossRefGoogle Scholar
  42. 42.
    Cui Y, Miller AB, Rohan TE (2006) Cigarette smoking and breast cancer risk: update on a prospective cohort study. Breast Cancer Res Treat 100:293–299PubMedCrossRefGoogle Scholar
  43. 43.
    Li CI, Malone KE, Daling JR (2005) The relationship between various measures of smoking and risk of breast cancer among older women 65–79 years of age (United States). Cancer Causes Control 16:975–985PubMedCrossRefGoogle Scholar
  44. 44.
    London SJ, Colditz GA, Stampfer MJ, Willett WC, Rosner BA, Speizer FE (1989) Prospective study of smoking and risk of breast cancer. J Natl Cancer Inst 81:1625–1631PubMedCrossRefGoogle Scholar
  45. 45.
    Cooper JA, Rohan TE, Cant ELM, Horsfall DJ, Tilley WD (1989) Risk factors for breast cancer by estrogen receptor status. Br J Cancer 59:119–125PubMedCrossRefGoogle Scholar
  46. 46.
    Yoo K, Tajima K, Miura S et al (1997) Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case-control analysis. Am J Epidemiol 146:307–314PubMedGoogle Scholar
  47. 47.
    Morabia A, Bernstein M, Ruiz J, Heritier S, Berger SD, Borisch B (1998) Relation of smoking to breast cancer by estrogen receptor status. Int J Cancer 75:339–342PubMedCrossRefGoogle Scholar
  48. 48.
    Manjer J, Malina J, Berglund G, Lennart B, Garne JP, Janzon L (2001) Smoking associated with hormone receptor negative breast cancer. Int J Cancer 91:580–584PubMedCrossRefGoogle Scholar
  49. 49.
    Gammon MD, Eng SM, Teitelbaum SL et al (2004) Environmental tobacco smoke and breast cancer incidence. Environmental Res 96:176–185CrossRefGoogle Scholar
  50. 50.
    Al-Delaimy WK, Cho E, Chen WY, Colditz G, Willett WC (2004) A prospective study of smoking and risk of breast cancer young adult women. Cancer Epidemiol Biomarkers Prev 13:398–404PubMedGoogle Scholar
  51. 51.
    Suzuki R, Orsini N, Mignone L, Saji S, Wolk A (2008) Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status–a meta-analysis of epidemiological studies. Int J Cancer 122:1832–1841PubMedCrossRefGoogle Scholar
  52. 52.
    Li Y, Baer D, Friedman GD, Udaltsova N, Shim V, Klatsky AL (2009) Wine, liquor, beer and risk of breast cancer in a large population. Europ J Cancer 45:843–850CrossRefGoogle Scholar
  53. 53.
    Lew JQ, Freedman ND, Leitzmann MF et al (2009) Alcohol and risk of breast cancer by histologic type and hormone receptor status in postmenopausal women. Am J Epidemiol 170:308–317PubMedCrossRefGoogle Scholar
  54. 54.
    Li CI, Chlebowski RT, Freiberg M et al (2010) Alcohol consumption and risk of postmenopausal breast cancer by subtype: the Women’s Health Initiative observational study. J Natl Cancer Inst 102:1–10CrossRefGoogle Scholar
  55. 55.
    Dorgan JF, Baer DJ, Albert PS et al (2001) Serum hormones and the alcohol breast cancer association in postmenopausal women. J Natl Cancer Inst 93:710–715PubMedCrossRefGoogle Scholar
  56. 56.
    Ginsburg ES, Walsh BW, Shea BF, Gao X, Gleason RE, Barbieri RL (1995) The effects of ethanol on the clearance of estradiol in postmenopausal women. Fertil Steril 63:1227–1230PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • Geoffrey C. Kabat
    • 1
  • Mimi Kim
    • 1
  • Amanda I. Phipps
    • 2
  • Christopher I. Li
    • 2
  • Catherine R. Messina
    • 3
  • Jean Wactawski-Wende
    • 4
  • Lewis Kuller
    • 5
  • Michael S. Simon
    • 6
  • Shagufta Yasmeen
    • 7
  • Sylvia Wassertheil-Smoller
    • 1
  • Thomas E. Rohan
    • 1
  1. 1.Department of Epidemiology and Population HealthAlbert Einstein College of MedicineBronxUSA
  2. 2.Division of Public Health SciencesFred Hutchinson Cancer Research CenterSeattleUSA
  3. 3.Department of Preventive MedicineStony Brook UniversityStony BrookUSA
  4. 4.Department of Social and Preventive Medicine, School of Public Health and Health ProfessionsUniversity of BuffaloBuffaloUSA
  5. 5.Department of Epidemiology, Graduate School of Public HealthUniversity of PittsburghPittsburghUSA
  6. 6.Department of Oncology, Karmanos Cancer InstituteWayne State UniversityDetroitUSA
  7. 7.Department of Obstetrics and GynecologyUniversity of California at DavisSacramentoUSA

Personalised recommendations